Heko Pharmacy Limited Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: Heko Pharmacy Limited Pharmaceutical Import Records from India — 23 Products, $14.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Heko Pharmacy Limited — Pharmaceutical Importer Profile (2026) | 23 Products, $14.4M Trade | TransData Nexus

Heko Pharmacy Limited

Pharmaceutical Importer · Tanzania · Antibiotics Focus · $14.4M Total Trade · DGFT Verified

Heko Pharmacy Limited is a pharmaceutical importer based in Tanzania with a total trade value of $14.4M across 23 products in 13 therapeutic categories. Based on 304 verified import shipments from Indian Customs (DGFT) records, Heko Pharmacy Limited is the #1 buyer in 7 products including Diclofenac, Gentamicin, Aminophylline. Heko Pharmacy Limited sources from 4 verified Indian suppliers, with Lincoln Pharmaceuticals Limited accounting for 66.2% of imports.

Heko Pharmacy Limited — Import Portfolio & Supplier Network

Heko Pharmacy Limited import network — 23 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Heko Pharmacy Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lincoln Pharmaceuticals Limited	$3.7M	227	66.2%
Theon Pharmaceuticals Limited	$1.2M	110	20.9%
Resonant Pharmaceuticals Private Limited	$698.7K	50

What Formulations Does Heko Pharmacy Limited Import?

Formulation	Value	Ships
(ceftriaxone for injection USP 1 GM	$184.1K	9
(ceftriaxone for injection USP 1 GM in	$160.0K	8
Diclofenac sodium with paracetamol	$150.0K	3
Diclofenac sodium with paracetamol	$119.9K	3
Nor-5 tablets (norethindrone acetate TAB	$115.6K	3
Paracetomol tablets BP dolomol	$100.0K	2
Nor-5 tabletsnorethindrone acetate	$80.0K	5
Diclofenac sodium with paracetamol tablets (vivian plus)(59168x10x10 TAB	$78.6K	3
Ciprofloxacin tablets b.p. 500 MG (ceepro-500)(44450x10x10 TAB	$76.7K	3
"harmless medicines for human consumption":(ceftriaxone for injection USP 1g) theoxone	$76.0K	5
Metronidazole oral suspension 125MG/5 ML	$75.3K	3
Diclofenac tablets BP 50 MG (vivian 50)(149600x 10x10 TAB)	$74.5K	2
Paracetamol oral suspension BP 125	$74.1K	5
Paracetomol tablets BP 500 MG (dolomol)(88530x10x10 TAB	$62.2K	3
Finride tablet (finasteride tablets	$61.1K	2

Heko Pharmacy Limited imports 254 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 23 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Diclofenac	Analgesics & Antipyretics	$2.7M	54	0.7%	1
2	Gentamicin	Antibiotics	$1.1M	22	2.2%	1
3	Azithromycin	Antibiotics	$900.0K	18	0.5%	3
4	Aminophylline	Respiratory & OTC	$875.7K	22	13.6%	1
5	Griseofulvin	Advanced Antifungals	$850.0K	17	2.4%	1
6	Amino	Nutritional Supplements	$800.0K	16	0.2%	12
7	Clotrimazole	Antifungals	$800.0K	16	0.9%	2
8	Hydrocortisone	Corticosteroids	$700.0K	14	1.1%	2
9	Lansoprazole	Gastrointestinal	$700.0K	14	0.2%	2
10	Artesunate	Antimalarial & Antiparasitic	$600.0K	12	0.3%	4
11	Pantoprazole	Gastrointestinal	$600.0K	12	0.0%	6
12	Atenolol	Cardiovascular	$500.0K	10	1.2%	5
13	Clarithromycin	Antibiotics	$500.0K	10	0.5%	4
14	Captopril	Cardiovascular	$474.2K	15	2.7%	3
15	Secnidazole	Advanced Antibiotics	$450.0K	9	1.5%	2
16	Furosemide	Diuretics	$400.0K	8	0.6%	17
17	Tetracycline	Antibiotics	$400.0K	8	2.4%	1
18	Lactulose	Gastrointestinal	$250.0K	5	1.9%	1
19	Metoclopramide	Gastrointestinal	$250.0K	5	1.1%	4
20	Ornidazole	Advanced Antibiotics	$200.0K	4	1.1%	1
21	Norfloxacin	Advanced Antibiotics	$165.5K	6	2.0%	7
22	Ambroxol	Respiratory & OTC	$150.0K	3	1.0%	2
23	Glibenclamide	Advanced Diabetes Medications	$54.1K	4	0.1%	12

Heko Pharmacy Limited imports 23 pharmaceutical products across 13 categories into Tanzania totaling $14.4M. The company is the #1 buyer for 7 products: Diclofenac, Gentamicin, Aminophylline, Griseofulvin, Tetracycline.

Heko Pharmacy Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Heko Pharmacy Limited is a pharmaceutical importer and wholesaler based in Dar es Salaam, Tanzania. Established to meet the growing demand for quality medicines, the company plays a pivotal role in the Tanzanian pharmaceutical distribution network. Operating from its headquarters in Dar es Salaam, Heko Pharmacy Limited sources a diverse range of pharmaceutical products, primarily focusing on finished formulations such as tablets, capsules, syrups, and injections. This strategic approach enables the company to cater to various therapeutic needs within the Tanzanian market.

The company's import activities are characterized by a significant volume of transactions, reflecting its substantial presence in the market. With a total import value of $14.4 million USD over 304 shipments, Heko Pharmacy Limited demonstrates a robust and consistent demand for pharmaceutical products. This extensive importation underscores the company's commitment to ensuring the availability of essential medicines across Tanzania.

2Distribution Network

Heko Pharmacy Limited's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products throughout Tanzania. While specific warehouse locations are not publicly disclosed, the company's operations are centered in Dar es Salaam, a key logistical hub in the region. This centralization facilitates streamlined distribution processes, enabling timely and reliable supply to various regions within the country. The company's logistics capabilities are tailored to handle a diverse product portfolio, ensuring that both urban and rural areas have access to necessary medications.

The geographic coverage of Heko Pharmacy Limited extends beyond Dar es Salaam, reaching multiple regions across Tanzania. This widespread distribution network is crucial for meeting the pharmaceutical needs of the population, particularly in underserved areas. By maintaining a comprehensive distribution system, the company plays a vital role in the national healthcare supply chain, contributing to the overall health and well-being of Tanzanian citizens.

3Industry Role

In Tanzania's pharmaceutical supply chain, Heko Pharmacy Limited functions primarily as a wholesaler and importer. By sourcing a wide array of finished pharmaceutical formulations from international suppliers, the company ensures a steady supply of essential medicines to the domestic market. This role is critical in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, facilitating the availability of a diverse range of medications.

Heko Pharmacy Limited's position as a key importer and wholesaler underscores its importance in the Tanzanian pharmaceutical sector. The company's extensive import activities, characterized by a total import value of $14.4 million USD over 304 shipments, highlight its significant contribution to the national healthcare supply chain. By maintaining a diverse product portfolio and a robust distribution network, Heko Pharmacy Limited plays a pivotal role in ensuring that Tanzanian healthcare providers have access to a wide range of pharmaceutical products necessary for patient care.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Heko Pharmacy Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Heko Pharmacy Limited's sourcing strategy exhibits a notable concentration on a select group of Indian pharmaceutical suppliers. The company's total import value from India amounts to $14.4 million USD, with 66.2% of this value derived from LINCOLN PHARMACEUTICALS LIMITED, 20.9% from THEON PHARMACEUTICALS LIMITED, and 12.6% from RESONANT PHARMACEUTICALS PRIVATE LIMITED. This concentration indicates a strategic choice to establish strong partnerships with a few key suppliers, potentially leading to favorable terms and consistent product quality.

However, such supplier concentration also introduces risks associated with dependency on a limited number of sources. Any disruptions in the supply chain from these suppliers—due to factors like production issues, regulatory changes, or geopolitical events—could significantly impact Heko Pharmacy Limited's ability to meet market demand. The company's reliance on a small group of suppliers necessitates robust contingency planning and the exploration of alternative sourcing options to mitigate potential risks.

The shipment data reveals a stable relationship with these suppliers, as evidenced by the consistent number of shipments over the years. This stability suggests effective communication and operational efficiency between Heko Pharmacy Limited and its suppliers. Nonetheless, the company should remain vigilant and proactive in managing these relationships to ensure continued supply chain resilience.

2Supply Chain Resilience

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

In Tanzania, the regulation of pharmaceutical products is overseen by the Tanzania Medicines and Medical Devices Authority (TMDA), established under the Tanzania Medicines and Medical Devices Act, Cap. 219. TMDA is responsible for ensuring the safety, efficacy, and quality of medicines and medical devices imported into the country. The Act provides TMDA with the mandate to regulate the importation and exportation of pharmaceutical products, ensuring that all imported medicines meet the required standards before they reach the Tanzanian market. (tmda.go.tz)

Key legislation governing pharmaceutical imports includes the Pharmaceutical and Poisons Act, which outlines the procedures for the registration, importation, and exportation of pharmaceutical products. This Act stipulates that no person shall import or export any pharmaceutical product unless it is registered and the importer holds the appropriate license issued by the Board. The registration process involves submitting an application accompanied by the prescribed fee and necessary documentation, ensuring that only approved products are available in the market.

The marketing authorization pathway for Indian generics involves obtaining registration from TMDA, which requires compliance with the regulatory standards set forth by the Authority. This process includes providing detailed information about the product, its manufacturing process, and quality control measures. Once registered, the product is granted marketing authorization, allowing it to be imported and distributed within Tanzania. This regulatory framework ensures that all pharmaceutical products, including generics from India, meet the necessary safety and efficacy standards before reaching consumers.

Frequently Asked Questions — Heko Pharmacy Limited

What products does Heko Pharmacy Limited import from India?

Heko Pharmacy Limited imports 23 pharmaceutical products across 13 categories. Top imports: Diclofenac ($2.7M), Gentamicin ($1.1M), Azithromycin ($900.0K), Aminophylline ($875.7K), Griseofulvin ($850.0K).

Who supplies pharmaceuticals to Heko Pharmacy Limited from India?

Heko Pharmacy Limited sources from 4 verified Indian suppliers. The primary supplier is Lincoln Pharmaceuticals Limited (66.2% of imports, $3.7M).

What is Heko Pharmacy Limited's total pharmaceutical import value?

Heko Pharmacy Limited's total pharmaceutical import value from India is $14.4M, based on 304 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Heko Pharmacy Limited focus on?

Heko Pharmacy Limited imports across 13 categories. The largest: Antibiotics (20.1%), Analgesics & Antipyretics (18.7%), Gastrointestinal (12.5%).

Get Full Heko Pharmacy Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Heko Pharmacy Limited

Heko Pharmacy Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Heko Pharmacy Limited?

What Formulations Does Heko Pharmacy Limited Import?

What Products Does Heko Pharmacy Limited Import?

Top Products by Import Value

Heko Pharmacy Limited Therapeutic Categories — 13 Specializations